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Abstract
Ferredoxins are iron-sulfur proteins that transfer electrons in different cel-
lular processes. In Bacillus cereus there are two genes for ferredoxins that have
been identified, one present with a [2Fe-2S] cluster (BC2795) and one with a [4Fe-
4S] cluster (BC1483). These proteins can potentially receive electrons from three
possible ferredoxin-NADP+-reductases, and further activate different enzymes. In
this project, the starting point was to purify and structurally characterize the two
ferredoxins in B. cereus and potentially their interactions with redox partners. For
the [4Fe-4S] ferredoxin several attempts to overexpress this protein was unsuccess-
ful. However, the [2Fe-2S] ferredoxin (106 amino acids, 11.4 kDa) was successfully
overexpressed in Escherichia coli. This [2Fe-2S] ferredoxin was purified in a series of
purification steps involving ammonium sulphate, desalting column, Q Sepharose or
DEAE columns, and Superdex 75 column. The purification procedure showed to be
troublesome because of possible low iron-sulfur cluster content, and because of low
UV-vis detection due to the absence of tryptophanes and tyrosines in the protein.
Due to the high content of apoprotein, it was also tried to establish a reconstitution
procedure for BC2795. The apoform of the protein was crystallized. Nevertheless, it
was not possible to solve the structure.
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1
Introduction
Already in the 1950s, three independent groups published findings about factors
involved in photoreduction of NADP+: in 1952 Methemoglobin-Reducing Factor
(MRF) (Davenport et al., 1952), in 1957 NADP+ reducing factor (Arnon et al., 1957),
and in 1958 Photosynthetic Pyridine Nucleotide Reductase (PPNR) (San Pietro and
Lang, 1958). In the beginning of the 1960s it slowly emerged that these three factors
might be the same. Three members of the DuPont Biochemistry group discov-
ered an electron-transferring protein in Clostridium pasteurianum that provided an
amber-coloured extract (Mortenson et al., 1962; Valentine, 1964). This turned out
to be the electron carrier between a hydrogenase and acceptors through reduction
and oxidation. Valentine and co-workers described the newly found protein as the
“most electronegative electron carrier found in oxidative-reductive chain” in bacteria
(Valentine, 1964). Based on these findings the name “Ferredoxin” was coined as it is
an iron containing protein involved in redox reactions. Otto Wartburg’s assumption
in 1914 that iron could be a catalysator in cell respiration was proven with the dis-
covery of Ferredoxin, which thus was the first identified iron-sulfur protein, shortly
1
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followed by the discovery of the Rieske protein in 1964 by Rieske (Höxtermann and
Sucker, 1989; Beinert, 2000b; Arnon, 1988; Rieske et al., 1964)
1.1 Iron-Sulfur proteins
“The range and diversity of iron-sulfur proteins are so broad that a com-
prehensive discussion of this family is no longer possible.” (Howard and
Rees, 1991)
By the 1990s over hundred iron-sulfur (Fe-S) proteins had been identified,
some being complex enzymes, others as small proteins with a weight below 15 kDa
(Cammack, 1992). They include membrane-bound electron transfer proteins, sol-
uble Fe-S enzymes, hydroxylases and dioxygenases, enzymes with molybdopterin
cofactor, enzymes containing sirohaem, proteins with catalytic Fe-S or mixed metal
clusters, enzymes with non-redox Fe-S clusters, regulatory proteins, miscellaneous
Fe-S proteins of unknown function, and simple Fe-S proteins. Whereas haemoglobin,
myoglobin, and the cytochromes also contain iron, iron-sulfur proteins are non-haem
proteins. The iron is not part of a porphyrin structure but is coordinated to cysteine
sulfurs from the protein and acid-labile sulfide, except in the case of rubredoxins,
where a single iron ion is linked to only the cysteine sulfurs of the protein (Cam-
mack, 1992). Thus, the iron and the acid labile sulfur ions form a variety of clusters
in simple geometric shapes, which play a pivotal role in the transfer of electrons (Br-
uschi and Guerlesquin, 1988). The functions of the Fe-S clusters are electron transfer,
electron delocalisation, substrate binding and catalysis, regulatory and sensing func-
tion (Beinert, 2000a). Hence, like other metalloproteins Fe-S proteins act as electron
carriers, in particular rubredoxins, ferredoxins, and membrane-bound electron trans-
fer proteins, which provide the uptake, release, and storage of electrons (Bruschi
and Guerlesquin, 1988; Cammack, 1992; Holm et al., 1996; Lovenberg et al., 1963;
Mortenson et al., 1962).
Other functions of the cluster are support of the structural configuration
of the proteins’ tertiary or quaternary structure, the uptake, binding, and release of
metals, and dioxygen binding with metal-O2 coordination and decoordination (Holm
et al., 1996). Fe-S proteins can also be involved in non-redox catalysis, where they
2
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bind small compounds to accessible ferric sites of the Fe-S clusters with extensive
Lewis acid properties. Fe-S proteins have also been found to be involved in the regu-
lation of gene expression, where the Fe-S clusters undergo reversible interconversion
and thus act as sensors of several redox- or iron-related stresses (Py and Barras,
2010; Cammack, 1992)
Membrane-bound electron transfer Fe-S proteins are large proteins that
can be composed of several subunits. By definition they carry additional prosthetic
groups like flavin, molybdopterin, siroheme, or other metal cofactors like Zinc, Nickel,
Cobalt, Cadmium, Gallium, Thallium, and Molybdenum (Cammack, 2013). How-
ever, some of these additional cofactors are only found in vitro. These complex Fe-S
proteins have their clusters arranged in series, separated by roughly 12 Å. Like in a
bucket brigade during a fire, the electrons are moved from one cluster to the next,
which can occur within nanoseconds through additional help from prosthetic groups
like haem or flavin (Cammack, 2013). Examples are the electron transport chains
with their complexes I, II, and III, or in photosynthesis the combination of hydro-
genase, photosystem I and II. The fast electron transfer is facilitated by minimal
reorganisation energy, which requires the reduction potential of the Fe-S clusters
to fit in with the overall direction of the electron movement in the transport chain
(Cammack, 2013).
Ferredoxins together with the rubredoxins and Rieske protein form the
group of simple Fe-S proteins, which primary function is the transport of electrons
in a variety of processes. These include photosynthesis, oxidative phosphorylation,
steroid hydroxylation, CO2 and H2 fixation, where “multiple factors influence the
redox potential range of Fe-S proteins” (Bruschi and Guerlesquin, 1988; Cammack,
2013). Besides conformational differences, each has its characteristic cluster and
ligands. Rubredoxins are the smallest and simplest Fe-S proteins with a molecular
weight of 6-7 kDa and a mononuclear [Fe(Cys)4] complex, where the iron is directly
linked to the sulfides of four cysteins (Cammack, 2013; Holm et al., 1996) (Fig. 1.1).
Ferredoxins are slightly larger proteins (more details p.4) with either a [2Fe-
2S], [3Fe-4S] or a [4Fe-4S] cluster (Fig. 1.2). Till the ’90s clusters up to [7Fe-
8S] were thought to exist, which were later shown to be two clusters. Due to the
poor resolution, these [3Fe-4S] and [4Fe-4S] clusters were previously seen as one
(Cammack, 2013). The [2Fe-2S] clusters are of rhombic shape, [3Fe-4S] clusters of
3
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Figure 1.1: Iron cluster in Rubredoxins (Cramer, 2007)
cuboidal, and [4Fe-4S] clusters cubic (Holm et al., 1996; Cammack, 1992). The iron
ion can be oxidized from Fe2+ to Fe3+, while the sulfur stays unchanged as S2− in
the clusters (Py and Barras, 2010). The cubic shape of [4Fe-4S] clusters is distorted
as the distance between S-S and Fe-Fe differs, making the sulfur distance 30% longer
(Cammack, 2013).
Figure 1.2: Fe-S cluster: A. single Fe ion, B. [2Fe-2S], C. [3Fe-4S], and D. [4Fe-4S]
(Holm et al., 1996)
Rieske proteins have a [2Fe-2S] cluster like ferredoxins but two histidines
replace two Cys-ligands holding the (Holm et al., 1996). Therefore, the conformation
is assumed to be distorted (Ali et al., 2014). They form a catalytic subunit of the
4
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cytochrome bc1 complex and thus play an electron transfer role in the respiratory
chain.
1.2 Ferredoxins
“[4056] A group of electron transfer factors found in plants and bacteria,
which are non-heme iron-sulfur proteins and which play an important role
in photo-synthesis, nitrogen and carbon-dioxide fixation, and respiration.
They are generally classified by the presence of either two or four iron
atom clusters and an equivalent amount of inorganic or ‘acid-labile’ sul-
phide bonded to the peptide chain through 4 cysteine sulfhydryl groups.
The two-iron ferredoxins are found primarily in plants and in blue-green
algae - sometimes referred to as chloroplast or ‘plant type’ ferredoxins,
the 4Fe ferredoxins are predominant in bacteria.” (Budavari, 1996)
1.2.1 Structure & Characteristics of ferredoxin
Ferredoxin has been defined as soluble protein electron carrier with a low reduction
potential, and equal amounts of iron and sulfur, where the highly acidic, oxygen
sensitive protein has a low molecular weight (6-12 kDa) with a characteristic EPR
spectrum of g=1.94 and serves as an electron shuttle (Fig. 1.3) (Arnon, 1988; Bruschi
and Guerlesquin, 1988; Yan et al., 2013). Yan et al. observed an instability of the
ferredoxin through a gradual loss of the Fe-S cluster over time (Yan et al., 2013).
Hence, some ferredoxins need to be handled only under anaerobic conditions. In its
holo-form ferredoxin exists in a stable fold, supported by its cluster. When the cluster
is lost, the protein can also lose its conformation and might become unstructered
(Yan et al., 2013). Therefore, the holoprotein is not as static as presented in crystal
structures, where plant and mammalian type [2Fe-2S] ferredoxins have a β-grasp
fold, formed by five stranded antiparallel β-sheets and an α-helix lying on top of it.
Their flexibility allows the sensing and transduction of signals based on the redox
state (Cammack, 2013).
Since the naming of ferrodoxins in the 1960s, two organisms have lead the
research: Clostridium pasteurianum and Spinacia oleracea (Buchanan et al., 1963;
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Hong and Rabinowitz, 1967, 1970; Malkin and Rabinowitz, 1966a,b; Mortenson et al.,
1962; Mortenson, 1964; Lovenberg et al., 1963; Tagawa and Arnon, 1962). Bacte-
rial ferredoxins can be a catalyst for reactions in which hydrogen gas or pyruvate
serves as reductant for synthesis of cellular constituents as in N2 fixation (Valentine,
1964). Here, ferredoxin functions as an electron-transport coenzyme for the Nitrogen
reductase system mediating electron to nitrogen reductase (nitrogenise) and the re-
duction of nitrite ion to ammonia. In C. pasteurianum, ferredoxin is required in the
formation process of acetyl phosphate and hydrogen from pyruvate, where it links
the pyruvate dehydrogenase and hydrogenase (Mortenson et al., 1962).
Figure 1.3: Selection of identified ferredoxin structures (Source: www.rcsb.org)
Consensus sequence The consensus sequence in ferredoxins provides informa-
tion about the type of cluster and thus allow a classification of the different types
of iron-sulfur proteins (Cammack, 2013). Ferredoxins carrying a [4Fe-4S] cluster
6
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present with a -C-x-x-C-x-x-C-x20−40-C- motif. If the ferredoxin contains two of
these clusters, the motif is repeated in the sequence. Another motif for ferredox-
ins with two [4Fe-4S] clusters is (-C-x-x-C-x-x-x-C-x-x-x-C-P-)2. Rothery & Weiner
(1991) substituted one of the ligand cysteine (Cys102) for a tryptophan, whereafter
the [4Fe-4S] turned into a [3Fe-4S] cluster (Rothery and Weiner, 1991). Plant and
mammalian type [2Fe-2S] Ferredoxins include a motif -C-x-x-x-x-(x-)C-x-x-C-x30-C-
and in Rieske proteins with [2Fe-2S] clusters -C-x-H-x15−17-C-x-x-H-. These His-
tidines are of importance as they are the main feature of Rieske proteins, whereas
in Ferredoxins only cysteine sulfurs ligate the cluster. Rubredoxins have an iron ion
ligated by two -C-x-x-C- motifs, where x are no cysteine residues, seperated by 20
to 30 amino acids.
1.2.2 Cluster Assembly & Reconstitution
“Despite the relative simplicity of Fe-S clusters in terms of structure and
composition, their synthesis and assembly into apoproteins is a highly
complex and coordinated process in living cells.” (Lill, 2009)
Cluster Assembly Three Fe-S cluster assembly pathways have been identified
so far: nitrogen fixation system (NIF), iron-sulfur cluster system (ISC), and sulfur
mobilization machinery (SUF) (Cammack, 2013; Chen et al., 2011; Ayala-Castro
et al., 2008; Shepard et al., 2011). In some organisms more than one pathway have
been discovered. In Cyanobacteria it appears that primarily the SUF system is active
and to some extent the ISC system, whereas in E. coli the situation is reversed.
In Mycobacterium tuberculosis and some archaea only the SUF system has been
detected till now. In eucaryotes, the homologue of the ISC pathway is common to
the mitochondria where as in the chloroplasts it is the SUF homologue. The ISC
pathway, also called AUS pathway based on the naming of the proteins, is seen as a
form of cluster housekeeping system, whereas the SUF occurs primarily under stress
conditions and the NIF is reserved for specialised clusters for specific enzymes (Chen
et al., 2011; Ayala-Castro et al., 2008).
The players of the Iron-sulfur-cluster (Isc) system are: IscR (regulator),
IscS (cystein desulfurase), IscU (scaffold), IscA (A-type protein), HscB (a DnaJ-like
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co-chaperone), HscA (DnaK-like chaperone), and Fdx (ferredoxin). The ISC as also
the SUF pathways are the main responsible for setting up Fe-S clusters under normal
and oxidative stress conditions in bacteria with SufA (A-type protein), SufS & SufE
(heterodimeric cystein desulfurase), and SufB, SufC & SufD (pseudo-ABC (ATP-
binding cassette)-transporter) - can act as scaffold (Shepard et al., 2011).
In all three systems two types of proteins fulfill the same function, a cysteine
desulfurase (NifS, IscS, or SufS) and a scaffold protein (NifU, IscU, or SufU). The
sulfur for the cluster is the product of a conversion of a free cysteine to alanine. The
cysteine desulfurase facilitates this reaction, in which a cysteyl persulfide is formed,
releasing an alanine. The cystein residue of a scaffold protein takes up the sulfate
and acceptes Fe2+ from a chaperone protein like apolscU. (Shepard et al., 2011)
cysteine
Cys desulfurase−−−−−−−−−−→ alanine+ sulfur (elemental)
Both iron and sulfur are toxic to the cell if left as free ions, where they
can form damaging reactive oxygen species(ROS), fueled by Fenton chemistry (Py
and Barras, 2010). Thus, for example, the Fe-S clusters in dehydratases can react
directly with univalent oxidants, which causes the inactivation of the dehydratase,
leading to the loss of Fe2+. This causes defects by DNA and other macromolecules
due to univalent oxidants like H2O2 (Py and Barras, 2010; Ayala-Castro et al., 2008).
Therefore the assembly of Fe-S cluster can only occur through coordinated biosyn-
thetic pathways (Chen et al., 2011; Ayala-Castro et al., 2008; Shepard et al., 2011).
The scaffold protein provides a platform in a protective environment for the assembly
of the Fe-S clusters with its cysteine residues, which have a labile structure and thus
transferable to the target proteins. Through this enclosed system, the cell is shielded
from the sulfur. Besides cysteine, the Fe-S clusters can also ligate to histidine, as-
partate, arginine and serine, as already demonstrated in rubredoxins (Shepard et al.,
2011). In E. coli three cystein desulfurases have been identified: IscS, SufS, CsdA
(cystein sulphinate desulphinase A) (Ayala-Castro et al., 2008).
Reconstitution of ferredoxin Due to the sensitivity to oxygen, ferredoxin loses
readily its cluster. To understand the protein and its structure as apo- and holo-
protein, the group around Rabinowitz conducted extensive work on the reconstitu-
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tion of the [4Fe-4S] cluster in Clostridium pasteurianum, where they showed that
it requires the addition of all three components: ferrous iron, sodium sulfide, and
2-mercaptoethanol (Malkin and Rabinowitz, 1966a,b; Hong and Rabinowitz, 1967).
If one component was missing, the reconstitution was not successful. [4Fe-4S] cluster
can assemble themselves from a mixture of iron, sulfide & thiol of cysteine peptide
under anaerobic conditions (Bruschi and Guerlesquin, 1988).
1.2.3 Redox potentials of Fe-S clusters
The reduction potential (E0) is the electron-transfer potential, measured in mV.
For proteins the reduction potentials are normally given at pH7, and donated as
biochemical standard reduction potentials (E’0) with the biochemical standard of
hydrogen reduction potential being -0.421V. Examples are shown in Fig. 1.4.
Figure 1.4: Reduction potential (Fd - ferredoxin) (Mitsui and Arnon, 1971; Tagawa
and Arnon, 1968)
The functions of Fe-S proteins is based on their Fe-S clusters and their
redox potentials (Holm et al., 1996; Py and Barras, 2010; Cammack, 1992; Valentine,
1964). In photosynthesis ferredoxin transferrers an electron to ferredoxin-NADP+
reductase, while in other cellular processes it receives an electron from ferredoxin-
NADP+ reductase and donates it to cellular proteins.
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Figure 1.5: Ferredoxin electron pathway
In the redox catalysis, the Fe-S cluster can reach very low reduction poten-
tials (Fig. 1.6). The oxidized [4Fe-4S] ferredoxin in spinach has a reduction potential
of 415 mV (Staples et al., 1996). Other ferredoxins have been found to vary between
ca. -300 and -455 mV (Tbl. 6.2). In some sources, the reduction potential of an
[2Fe-2S] cluster can vary between -240 to -460 mV for [2Fe-2S] ferredoxin and 0 to
-645 mV for bacterial [4Fe-4S] ferredoxin (Cammack, 1992). Buckel & Thauer state
that the ferredoxin redox potentials are close to that of the hydrogen electrode at
pH 7.0 (Buckel and Thauer, 2013).
Independent of the system as for example in the respiration chain or in pho-
tosynthesis, ferredoxin always takes an electron from a source with a more negative
reduction potential and transferring it to an acceptor with a more positive reducing
potential value. In general there are two possible scenarios: Either NAD(P)H is the
source of electrons, which with the help of ferredoxin NADP+ reductase (FNR) re-
duces ferredoxin that is then oxidized by another electron acceptor like cytochrome
P450 (CYP) or isu1-3 in the human mitochondria (Sheftel et al., 2010). Here two
[2Fe-2S] ferredoxins participate in three pathways: ferredoxin 1 (adrenodoxin) is in-
volved the catalysis of steroidogenesis, ferredoxin 2 supports the haem A formation
path and the Fe-S cluster assembly (Sheftel et al., 2010). The other situation can
be where an electron from a donor like PSI (Photosystem I) in the chloroplast is
transferred to a ferredoxin, which then reduces NADP+, producing NADPH. The
last step is also facilitated by ferredoxin NADP+ reductase (Arnon, 1988; Tagawa
and Arnon, 1962).
The reduced ferredoxin can be a strong reducing agent. Whereas the oxi-
dation state of iron can shift from Fe2+ to Fe3+, the oxidation state of sulfur stays
unchanged at S2−. This makes the iron ions the main reduction agents in the clus-
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Figure 1.6: Characteristics of Fe-S clusters (Holm et al., 1996)
ter (Green et al., 2003). In Clostridium pasteurianum, the [4Fe-4S] ferredoxin has a
redox potential (E’0) of -417 at pH 7.55, where it is an electron-mediating catalyst
for the production and utilization of hydrogengas by bacteria (Tagawa and Arnon,
1962). In B. subtilis the [4Fe-4S] cluster has a redox potential of -385 mV at pH 7.2
(Green et al., 2003).
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Higher plants potential (mV)
S. oleracea -415
P. sativum, I -425
P. sativum, II -410
M. sativa -415
Z. mays -390
Equisetum telemateia (horsetail) -405
Green algae
Scenedesmus obliquus -385
Red algae
Porphyra umbilicalis -380
Porphyridium cruentum -405
Porphyridium aerugineum -394
R. palmata -402
Cy. caldarium -340
Blue-green algae
S. maxima, I -390
S. maxima, II -310
Spirulina platensis -381
Nostoc MAC, I -350
Nostoc MAC, II -455
Ch. fritschii -340
Anabaena variabilis -355
Aphanocapsu 6714 -375
M. laminosus -325
Oscillatoria limnetica -346
Table 1.1: Em values of ferredoxins, 0.15M-Tris/HCl, pH8.0, 25◦C (Cammack et al.,
1977)
1.2.4 Ferredoxin Reductases
Ferredoxin NADP+ reductases (FNR) are flavoenzymes with a non-covalently bound
flavin adenine dinucleotide (FAD) that transfer electrons between NADP(H) and
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ferredoxins or flavodoxins (Pueyo et al., 1991). Two members of the oxidoreductase
enzyme family have been identfied as ferredoxin reductases: ferredoxin/flavodoxin:NADP(H)
oxidoreductases (EC 1.18.1.2) and ferredoxin:NAD(H) oxidoreductase (EC 1.18.1.3).
Each catalyzes the electron transfer between the ferredoxin and either NADP(+/H)
or NAD(+/H) (Skråmo et al., 2014). Seo et al. categorized them into four classes:
I. plant type including cyanobacterial FNR,
II. bacteria type, e.g. E.coli FNR,
III. mitochondria or adrenodoxin reductase type, and
IV. a novel type - NADPH-thioredoxin reductase like, which differs from the general
thioredoxin reductase through the lack of the di-cysteine motif (-CXXC-), which is
essential for thioredoxin reductase (Seo et al., 2004).
Depending on the system, they utilize ferredoxins or flavodoxins as an electron donor
as in chloroplasts and cyanobacteria or acceptor, which is the case in bacteria. One
example of redox partners for ferredoxin is cytochrome P450 in Pseudomonas putida
(Sevrioukova et al., 2003).
2 reduced ferredoxin + NADP+ + H+ 
 2 oxidized ferredoxin + NADPH
Figure 1.7: Electron transfer complex between ferredoxin and ferredoxin-NADP(+)
reductase
1.2.5 Ferredoxin in Bacillus cereus
The species group Bacillus cereus includes besides B. cereus also Bacillus anthracis
producent of anthrax, Bacillus thuringiensis, a pesticide, and Bacillus weihenstepha-
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nensis, a food-borne pathogen (Fig. 1.8). The bacterium B. cereus is a gram-positive,
facultative anaerobic soil-dweller that can be cause of two types of food-born illnesses
in humans manifested by diarrhoea or enetic syndromes, particularly known for the
Fried Rice Syndrome at a optimal temperature window of 25-35 ◦C (Candelon et al.,
2004), (Drobniewski, 1993), (Granum and Lund, 1997)
Figure 1.8: Bacillus cereus family genetic similarity (Helgason et al., 2000)
So far no papers have been published on ferredoxins in B. cereus. Two
ferredoxins have been identified by their amino acid sequence in B. cereus as they
are homologous to sequences in other members of the B. cereus family. For BC2795
71 identical amino acid sequence found till today. Based on consensus sequence,
following information can be extracted from NCBI12 databank: BC2795 (Q81CG9)
with a [2Fe-2S] cluster has 106 amino acids, a molecular weight of 11.4 kDa, BC1483
(Q81FT6) with a [4Fe-4S] cluster has 82 amino acids, and a molecular weight of 8.8
kDa.
It is assumed that at least one of the two ferredoxins is an electron shuttle
in the cytosol similar to the ferredoxin in B. subtilis or in P. putida (Seo et al., 2009;
Sevrioukova et al., 2003) (Figs. 1.9, 1.10).
1BC1483 http://www.ncbi.nlm.nih.gov/protein/NP_831262.1
2BC2795 http://www.ncbi.nlm.nih.gov/protein/NP_832547.1
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Figure 1.9: BC2795 electron pathway in Bacillus cereus
Figure 1.10: Electron pathway
1.3 Research aim of this project
In their simplicity and small size, ferredoxins play a pivotal role in the electron
transport in nature. Although in some context ferredoxins can be replaced by for
example flavodoxins, the lack of ferredoxin in a system can be fatal. Therefore it
is important to understand their structure, their interaction with redox donors and
acceptors, and how they activate different enzyme systems - the redox networks. Till
now there have been no published studies about ferredoxins in B. cereus or related
organisms like B. weihenstephanensis, B. thuringiensis, and B. anthracis.
The main aim of this project was to purify and structurally characterize and
understand the selectivity and specificity of the ferredoxins BC1483 [4Fe-4S] and
BC2795 [2Fe-2S] with respect to the three so far identified redox partners ferredoxin-
NADP+ reductases in B. cereus.
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These stage aims were targeted to achieve this goal:
• Expression of the ferredoxins BC1483 [4Fe-4S] and BC2795 [2Fe-2S]
• Development and optimizeation of the purification procedures
• Screening for crystallization conditions
• 3D structure determination by x-ray crystallography (Synchroton)
• The functional aspect of the ferredoxins and their redox partners
16
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Material & Methods
The following chapter is an overview of the methods and general materials used in this set of
work. For more detailed protocols, the reader is referred to the appendix section on p.71-80.
2.1 Molecular Cloning of Ferredoxin
The vectors for the two ferredoxins in B. cereus BC1483 and BC2795 have been ordered
from GenScript precloned into the pET22b(+) cloning vector using the restriction enzymes
NdeI and BamHI for both (fig. 2.1, appx. p.70). For the experiment E. coli One Shot BL21
(DE3)1 cells (Invitrogen) were used, and additionally for BC1483 also C41 (DE3)2 cells
(Lucigen). Whereas BL21 cells are in general suitable for an efficient protein expression,
the C41 strain, a derivative of BL21, is seleceted, when there is a possibility of the target
protein being toxic to the host cell.
The ordered plasmids needed to be transformed and incorporated into the host cells
for expression. For this purpose competent host cells were transformed with the prepared
1BL21(DE3): F- ompT hsdSB (rB-mB-) gal dcm (DE3)
2C41(DE3): F- ompT hsdSB (rB-mB-) gal dcm (DE3)
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Organism Gene name Protein name Length (aa) Mass (kDa) UniProt
Bacillus cereus BC1483 Ferredoxin 82 8.8 Q81FT6
Bacillus cereus BC2795 Ferredoxin 106 11.4 Q81CG9
Table 2.1: Details about BC1483 and BC2795
10 20 30 40 50 60
MAKYTIVDKD TCIACGACGA AAPDIYDYDD EGIAFVTLDD NQGIVEIPDV LIEDMMDAFE
70 80
GCPTDSIKVA DESFDGDALK FE
Table 2.2: BC1483 - Sequence
10 20 30 40 50 60
MPKLTIEGAG TFDVKEGTKL VLAIEDSGVN ILHRCGGNAR CTTCRVEILA GDFCEASANE
70 80 90 100
KHAMTEKGIE DHLRLSCQMR VHKDIVVRPV LTVENSGLDA GPRPAE
Table 2.3: BC2795 - Sequence
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2.2. SDS-PAGE: SODIUM DODECYL SULPHATE
POLYACRYLAMIDE GEL ELECTROPHORESIS
Figure 2.1: Modified pET-22b cloning vector (Novagen)
plasmids (p.72). The cells were plated on Lysogeny broth (LB) agar plates containing the
required antibioticum. The BL21 strain carries an ampicillin resistance gene and the C41
strain has a resistance against chloramphenicol. The agar plates were screened for positive
transformers on the next day, which were then tested for overexpression (p.73-74). For
storage, batches of 800 µl of the successful overexpression culture were mixed with 200 µl
glycerol and stored as bacteria stock by -80◦C.
2.2 SDS-PAGE: Sodium Dodecyl Sulphate Polyacrylamide
Gel Electrophoresis
SDS-PAGE is a denaturing electrophoresis, where the gel is made up of cross-linked poly-
merised acrylamide monomers and N,N’-methylene bisacrylamide. The result is a porous
gel that allows the separation of denatured proteins by their size. The pore size depends on
the concentration of acrylamide. This can be taken a step further by a changing gradient
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across the gel. Hence a 4% PAGE gel will have only larger pores, whereas the standard gel
used in the here presented work had a gradient of 4%-12%. Thus, the pores decrease in size
in downwards direction on the gel, allowing a better separation of the smaller sized proteins.
By applying Sodium Dodecyl Sulphate (SDS) through the loading buffer3, an equal negative
net charge is distribution along the denatured polypeptide chains. SDS is a hydrophobic
12-carbon chain detergent with a polar, sulfated head. By interacting with hydrophobic
parts of the protein, the tertiary and quarternary structures are disrupted. The sulfated
hydrophilic part leaves the detergent protein complex highly soluble. Through heating up
the proteins above 60◦C, the binding of SDS is improved through the motion of the protein
molecules, thus allowing space between the molecules. After loading the gels with 20 µl (10
wells) or 10 µl (15 wells) sample, they were run at 200 V for 32 to 35 minutes by 100 W at
ca. 120 mA. The ladders applied were Novex R© Sharp Pre-Stained (Invitrogen), and later
on Spectra multicolor Low Range Protein Ladder (Thermo Scientific).
To identify the protein bands, the gels were stained with Stain Novex 0.1% Brilliant
Blue (Coomassie), which were after the absorption process with short heat treatment and
five minutes rest, destained with a gel destainer containing 10% Ethanol and 7.5% acetic acid
in three steps of five minutes with 30 second heat treatment. Alternatively gels were stained
with InstantBlueTM (Expedeon), which does not require any specific staining procedure or
destaining , only a resting phase of at least 15 minutes (p.74). Better results are achieved
by storing the gel over night in Instant Blue, which is then exchanged for mqH2O. The gels
were then packed in resealable plastic bags and stored at 4◦C.
2.3 Overexpression
For the overexpression of both ferredoxins, between six to twelve litre of bacterial culture
were grown following to protocol (p.75-76). Cells labeled DE34 carry the λ DE3 lysogen.
This lysogenic phage contains the sequence for T7 RNA polymerase, controlled by the
lacUV5 promoter. With the help of Isopropyl β-D-1-thiogalactopyranoside (IPTG), the
T7 RNA polymerase will be activated in the overexpression, hence allowing the expression
of the foreign DNA, in this case the ferredoxins of B. cereus by the E. coli cells (fig. 2.1). To
improve the cluster formation and sustentation, ferric Ammonium Citrate [0.1mg/ml] was
added to the growth medium (Nakamura et al., 1999).
The overnight (ON) culture was grown in LB medium and the required antibi-
oticum by 30◦C and 225 rpm. For the day culture 25 ml ON culture were transfered to
3NovexrNuPAGErLDS Sample Buffer (4x)
4BL21(DE3), C41(DE3)
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Terrific Broth (TB) medium, including phosphate buffer and antibioticum for six to eight
hours. When an optical density (OD) between 0.8 and 1.0 at a wavelength of 600 nm was
reached, the day bacterial culture were transfered to the prepared 1l overexpression cultures
(25 ml each), which had the same set up as the day culture. Once the OD600 was between
0.8 and 1.0, the temperature was immediately dropped to 20◦C and IPTG added to each
bottle. The cultures were given over night (14-16h) to overexpress. The cells were collected
through centrifugation (6600 ×g), and then bagged, flattened out, and frozen by -20◦C in
30 g batches.
2.4 Lysis of bacterial cells with X-press
To be able to purify the target protein, the rigid cell walls have to be broken down (p.77).
Therefore, the frozen cells plates (max. 30 g) were crumbled in liquid nitrogen and then
mashed with the help of the X-press (AB Biox) by forcing the cells through a 2 mm hole at
-20◦C under a pressure of 250 Bar (Edebo, 1960). Choosing the mechanical way instead of
the chemical provides a higher yield due to the cells being more sufficiently broken down.
For efficient disruption both, the frozen cells and the removable parts of the X-press were
kept in -20◦C for at least four hours before use. The lysed cell paste was then applied to a
variety of purification procedures with the final aim of a pure target protein.
2.5 Purification
Before the protein purification, any non-protein part of the cells have to be removed. Where
possible, the procedures were performed at 4◦C (p.77). Therefore the lysed bacteria and
[100mM] Tris-buffer (pH 7.5) were mixed to a colloid solution, followed by centrifugation
(48000 ×g, 60 min). Thereafter, the DNA was precipitated by adding Stryptomyecin Sulfate
Solution (pH 7.5) dropwise to a final concentration of 2.5%, followed by centrifugation (48000
×g). DNA is removed to avoid congestion of the purification columns by viscosity of DNA.
As reducing agent dithiothreitol (DTT) was initially used. However, in the later purification
rounds it was changed to β-mercaptoethanol (BME) for a better preservation of the iron-
sulfur cofactor during purification.
2.5.1 Ammonium sulfate precipitation
The supernatant should only contain the protein part of the overexpression cells. However
this includes the proteins of the E. coli host cells as also the overexpressed ferredoxin. As
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a first purification step, the proteins were separated by ammonium sulfate. The “salting
out” level of proteins differs and thus they will precipitate by different concentrations of
ammonium sulfate. It was found that 0.23g/ml sufficiently precipitates the ferredoxin, as
shown by SDS-PAGE. More detailed description of this process can be found in the result
section (p.28) and as protocol (p.77).
2.5.2 Chromatographic protein purification
ÄKTApurifier & Unicorn The chromatographic separation process was an auto-
matic procedure using the ÄKTApurifier system (GE Healthcare - Amersham pharma-
cia biotech) and the Unicorn Computer Programme. The monitoring of the samples was
achieved through the measurement of the absorbance at three wavelengths and detection of
the conductivity.
Wavelenghts Generally proteins are monitored at 280 nm. For the final exper-
iments, the wavelengths 280 nm, 305 nm, and 330 nm were used. The choices of wavelengths
will be explained in more detail in the results section as the BC2795 ferredoxin has no Ty-
rosine and Tryptophan (p.30).
Desalting column The first step after the ammonium sulfate precipitation was to re-
move the hight salt content from the protein sample to allow sufficient purification with
the ÄKTApurifier afterwards. The salt concentration would affect the separation by ion
exchange as the protein would not bind to the column due to the surplus of salt. Therefore
the pellet from the previous step was diluted in Buffer A until the solution was clear (max.
20 ml). After filtering the sample through a sterile 0.20 µm filter, it was applied to a 70 ml
desalting column with Sephadex G-25 Superfine raisin (GE Healthcare) (p.78).
Ion Exchange column (IEX) Ion Exchange chromatography (IEX) separates the
proteins based on their charge. For a protein to bind to an anion exchange column the pH
of the running buffer has to be at least one pH value higher than the pI of the protein.
Then the protein has enough positive charge to bind to the column, and by increasing the
ionic strength (salt content) of the running buffer the different proteins will be eluted from
the column depending on their charges. To obtain an optimal purification procedure for
the ferredoxin, two different anion exchange columns were tested out. To further improve
the procedure the length of the gradient was optimized as well as including step-gradient
to better separate peaks. The IEX columns used were equilibrated and run with either a
Tris-HCl [50mM] buffer at pH 8.2, or the same buffer containing 100 mM KCl] (p.79). By
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increasing the salt concentration of the running buffer (KCl in buffer B) up to [1M], the
affinity of the different proteins to the raisin would decrease till different proteins would be
eluted based on their affinity to the positive raisin. To optimize the purification procedure,
both linear and step gradients were investigated.
The standard column in the literature for the purification of ferredoxin has been
the Diethylaminoethyl (DEAE) column (Green et al., 2003; Malkin and Rabinowitz, 1966a,b;
Mortenson, 1964; Nakamura et al., 1999). This weak anion exchange column contains DEAE
Sephadex raisin, made up of crosslinked dextran (Porath and Flodin, 1959).
Q Sepharose High Performance raisin (GE Healthcare) is a strong anion exchanger.
Q Sepharose is made up of crosslinked agarose beads, extracted from seaweed, which have
been modified to allow an even stronger anion exchange. This column binds the anionic
proteins more tightly and thus, they are not eluted as easily as with the DEAE column,
which was chosen to allow the ferredoxin to interact longer with the column. The protein
samples were loaded to a 10 ml (2 × 5ml) on both columns.
Gelfiltration column To separate the proteins by their size, size exclusion chromatog-
raphy was used, using a Superdex 200 column. Superdex beads are composed of crosslinked
agarose covalently bound to dextran. Here the smaller protein molecules have to pass
through the porous beads, wheras the bigger molecules just move along the outside of the
raisin beads. Therefore the bigger protein molecules are eluted before the smaller ones. 100
µl were loaded onto a 120 ml column filled with HiLoad 16/60 Superdex 200 exclusion raisin
(GE Healthcare) (p.80). A Hepes buffer [50 mM] with [100 mM] KCl was used, with a pH
of first 7.5, later 8.2. The purity of the collected samples were controlled with SDS-PAGE
after the IEX and the gel filtration.
Ultra filtration After the purification steps with IEX and the Gel filtrations the sam-
ples were concentrated by Ultra filtration with Amicon Ultra-15 Centrifugal Filter Unit
(Millipore) and a cut-off value 10 K.
2.6 Protein Crystallography Methods
2.6.1 Protein concentration
Bradford assay For the crystallization trials, the protein concentration were between
2 and 8 mg/ml. Due to the lack of tryptophan and tyrosin for BC2795, the determination
of the protein concentration from measurements at 280nm is not possible. The Bradford
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assay bypasses this problem. The concentrated protein samples (20 µl) are mixed with 1 ml
Coomassie Brilliant Blue G-250, which will lead after an incubation period of five minutes
to a change in colour from violet towards blue, depending on the concentration. From
the absorbance at 595 nm the concentration can be determined with the help of UV-vis
spectroscopy the concentration can be determined. Concentrations higher than 1 mg/ml
lead to barely detectable changes in the blue hue due to saturation. Therefore the samples
had to be diluted in smaller steps to find an agreement. The standard curve was based on
the concentration with bovine serum albumin (BSA) [0.1-1.0 mg/ml] (GBiosciences).
UV-vis spectroscopy The spectroscopy was performed with Agilent 8453 spectropho-
tometer (Agilent Technologies) and the computer programme 845 x UV visible Chem Station
(Agilent Technologies).
2.6.2 Protein crystallization
To achieve crystallization, the solution needs to reach the supersaturated state, where nucle-
ation can start and crystals grow. Crystallization robots were used for an efficient screening
for crystallization conditions with a low requirement of protein for each condition (21µl).
The robots were provided by the Structural Biology Core Facility at the University Hospital
Rikshospitalet: first the Oryx6 Robot (Douglas Instruments Ltd) was used, which in later
crystallization screenings was exchanged for the Mosquito LCP (TTP Labtech). Each is
equipped with a set up for trays with space for 96 sitting drop conditions.
The crystallisation suits applied were:
Index (Hampton Research)
JCSG+ (Qiagen)
Morpheus I & II (Molecular Dimensions Ltd.)
Natrix TM (Hampton Research)
Natrix TM2 (Hampton Research)
Wizard Classic 1 & 2 (Rigaku Reagents, Inc.)
The trays were monitored with a standard light microscope for the growth of
crystals, which were then used for X-ray data collection. Due to the low yield, there was
in most cases not enough protein left for further optimization. For the transport to the
synchroton, the crystals were transferred with a loop into a cryo-solution (70% crystallization
stock, 30% glycerol), shock-frozen and stored in liquid nitrogen.
24
2.7. CRYSTAL HARVESTING, DATA COLLECTION & PROCESSING
2.7 Crystal harvesting, data collection & processing
Crystals from the screening setups were used for X-ray data collection. The X-ray diffraction
data is collected at 100 K, therefore the crystals need first to be transferred to a cryo-solution
containing an antifreeze (70% crystallization solution, 30% glycerol or glucose). Then the
crystals were picked by nylon loops (Hampton Research), flash-frozen and stored in liquid
nitrogen.
Data collection was performed at beamline ID23-1 at the European Synchrotron
Radiation Facility (ESRF) in Grenoble, France. The diffraction images were indexed with
XDS or MOSFLM (Kabsch, 2010; Battye et al., 2011), the space group determined with
POINTLESS and scaled with AIMLESS (Evans, 2011)Evans2011 in the CCP4 program
package (Winn et al., 2011)Winn2011. For solving the structure with molecular replacement
the program PHASER (McCoy et al., 2007) was used as well as the MrBUMP automatic
pipeline (Keegan and Winn, 2007) by using several homologous models.
2.8 Structure determination
CCP4 Several programs are used for processing the data as also for solving and verifying
the structure.
CCP4 (Collaborative Computational Project No. 4) suite is a selection of over 100
programs, which together facilitate the different steps of the structure determination based
on the collected diffraction data of the crystals (CCP4project, 2006).
- iMosflm allows the data processing from various types of detectors
- Phaser solves structures via molecular replacement, where molecules from the Protein Data
Bank (PDB) with a high sequence homology are applied as molecular replacement starting
model
- REFMAC refines the structures by using by the use of on least squares or loglikelihood
residuals optimization.
COOT The Crystallographic Object Orientated Toolkit was developed for model build-
ing, completion and validation of the collected data. It allows a 3D electron density map
interpretation, manipulation and pictorial presentation of the results.
PyMOL Python enhanced Molecular Graphics Program allows the final production of
the graphical presentation of the protein molecule for the scientific presentation.
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2.9 Cluster reconstitution
As ferredoxin can lose the cluster quite easily, reconstitution experiments were performed
based on the procedures of Malkin and Rabinowitz (1966b). 100 µl of 1 mg/ml protein
were incubated at 37◦C for 15 min together with 1 µl [1M] β-Mercaptoethanol (BME). To
reconstitute the cluster, 10 µl FeSO4(NH4)2SO4 [1mM] and 10 µl Na2S [10mM] were added,
filled up with TrisHCl buffer (pH 8.2) to 1 ml and reincubated for 10 min at 37◦C. It was
additionally tested if the reconstitution were more successful under anaerobic conditions by
applying the Schlenk line and argon. Here for each sample and each step the cuvette/sample
underwent a procedure by flushing for 15 minutes with argon, then 15 minutes with vacuum
suction and then flushed with argon again for 15 minutes to remove the presence of oxygen.
This was done for the buffers and protein samples, both before and after mixing with BME,
as well as after mixing with the iron and sulfur solutions.
2.10 BC1483 - Sequence confirmation
The sequence of BC1483 plasmid was counterchecked for its correctness. With a NanoDrop
2000 UV-vis Spectrophotometer (Thermo Scientific) the plasmid concentration was deter-
mined. This sample was then diluted and sent to GATC Biotech for sequence analysis.
The sample was prepared in a 1.5 ml Eppendorf tube with
5 ul DNA [80-100 ng/µl] (2.5 µl Plasmid -> ca. 95 ng) + 2.5 µl mqH2O
5 µl primer [5 µM]
10 µl total sample
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Results & Discussion
3.1 Ferredoxin with [2Fe-2S] cluster - BC2795
3.1.1 Molecular Cloning of Ferredoxin
Figure 3.1: BC2795 cultures with 10 µl cells and 1, 2 or 3 µl plasmid
The Bl21 cells carrying the BC2795 gene were successfully expressed in all three
concentrations (10 µl cells with either 1, 2, or 3 µl plasmid). All three conditions grew
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colonies on agar dishes (fig. 3.1). A and B stands for two different colonies from the
same condition. The zero plasmid control did not grow any colonies as expected. In the
overexpression test run all three concentration overexpressed the target protein sufficiently
well (fig. 3.2). The SDS-PAGE did not show any recognizable differences.
Figure 3.2: Test overexpression of BC2795 (11 kDa)
3.1.2 Overexpression
The first overexpression was run from the 2µl batch (2A), which was not successful poten-
tially due to lack of clusters (fig. 3.3). As the addition of ferric ammonium citrate also did
not show any improvement, bacterial stocks from culture 1A were used for the overexpres-
sion with ferric ammonium citrate. In average, one litre of bacterial culture would yield
between 25 - 30 g cells.
The aim of the overexpression was to yield primarily holo-ferredoxin. Several
attempts to obtain a higher yield of holo-ferredoxin was performed including addition of
iron and sulfur during overexpression. The addition of the iron caused a red colour in the
yielded cells after the overexpression, implying the uptake of iron in the cells. If this was
however due to proteins of E. coli or B. cereus could not be identified at this step. The
additional iron did at least not proof negative for the cell growth.
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Figure 3.3: BC2795 cell yield after overexpression (2A) and with added iron (1A)
3.1.3 Purification
The first purification attempts was a three step purification procedure with ammonium
sulfate precipitation, anion exchange chromatography and gel filtration. It was tried as it
has been shown to be successful in the purification of several other untagged proteins from
Bacillus cereus (Hammerstad et al., 2013; Røhr et al., 2013; Skråmo et al., 2014; Tomter
et al., 2013).
3.1.3.1 Ammonium sulfate precipitation
The first purification step was the ammonium sulfate precipitation. To find the optimal
precipitation window, ammonium sulfate was added in three steps. The total amount added
should not exceed is 0.43g/ml. The first addition was therefore a third (0.14g/ml), which
caused only a very light precipitation. Thus, the ammonium sulfate concentration was fur-
ther increased to a half (total 0.21g/ml), which achieved recognizable precipitation. An
additional quarter (0.105g/ml) ammonium sulfate was then added, resulting in a precipita-
tion in appearance similar to thick cloudy apple juice. In the third step a further quarter
(0.105g/ml) ammonium sulfate was admixed resulting in a solution like thick pear juice.
After each addition step (0.21g/ml, 0.32g/ml, 0.43g/ml) the solution was centrifuged and a
sample applied to the SDS-PAGE (fig. 3.4). The gel shows the target protein in the first pre-
cipitation step with a 0.21g/ml ammonium sulfate concentration. Therefore the subsequent
precipitations were done in one step, collecting the pellet for the subsequent purification
steps.
In the following experiments, the concentration was increased from 0.21g/ml to
0.23g/ml to secure as much target protein as possible. The change had no overall impact on
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Figure 3.4: Ammonium sulfate precipitation
the purification. As 0.23g/ml is already half of the maximum amount that can be added,
the question arose, if this purification step could not be improved by narrowing this step by
removing other easily precipitating proteins. Till 0.12g/ml no precipitation occurred, and
up to 0.16g/ml only a very light precipitation was observed.
The ideal precipitation window for BC2795 is 0.16-0.23g/ml. However, the re-
moval of the precipitated proteins of lower than 0.16g/ml had no impact on the purification
procedure and therefore no changes were made to the one step (0.23g/ml) ammonium sulfate
precipitation.
3.1.3.2 Ion exchange chromatography (IEX) and gel filtration (GF)
In this section two different columns were tested for IEX: HP Q as it has been successful
in separation across a variety of B. cereus proteins, and DEAE, based on the ferredoxin
literature (Mortenson, 1964; Green et al., 2003). Due to the intertwined relationship of the
outcome of IEX and GF, the results will be presented together, where possible.
The first attempts of IEX were done with a HiLoad 26/10 Q Sepharose HP column
with a linear salt (KCl) gradient of 0-60% (fig. 3.5). The protein did not bind to the column
and hence, it was already eluted shortly after the injection. The samples were collected and
further purified with gel filtration (Fig. 3.6). This purified sample was later used for the
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first crystallization round.
Figure 3.5: Linear Gradient - blue arrows: Protein band with 11 kDa
Figure 3.6: Gelfiltration of Fig. 3.5 and SDS-PAGE
To achieve a binding of the protein to the column, the column was exchanged for
a HiTrap Q HP 5ml column. With the new column a different protein separation profile
was observed. Therefore a step gradient was introduced with 30% - 39% - 42%, based on
the observed peaks in the linear gradient (Fig. 3.7). At that stage the focus was on larger
280 nm peaks in the chromatogram because the search was after an overexpressed protein.
The SDS-PAGE showed afterwards that in each case the protein was still not binding to
the column. Therefore, the 5 ml column was exchanged for a new model and the pH of the
Buffer A and B changed from 7.5 to 8.5. For a larger filtration volume, the 5 ml column
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was extended to a 10 ml column.
Figure 3.7: Linear vs. step gradient - 5ml HP Q column
Very quickly into the work it became clear that the 280 nm detection by the
ÄKTApurifer were not as easily interpreted for the target protein as commonly observed.
A closer look at the amino acid composition showed that BC2795 has neither tyrosine nor
tryptophan, something it shares with the ferredoxin sequences identified in other members
of the B. cereus family (Fig. 3.8).
Figure 3.8: Sequence comparison of BC2795 with the equivalent sequence in B.
thuringiensis, yellow: Cysteines for cluster binding
With this information a more detailed chromatogram was needed. An extended
step gradient was performed across two samples from 0% to 45% in six steps (Fig. 3.9).
The SDS-PAGE identified the eluding of 11 kDa proteins in sample 8 at a salt concentration
of 35% with some traces in sample 7 and 9, showing that the BC2795 now bound to the
column after increasing the pH. Through repetition and changing of the setting, the eluding
window was set as 30-36% (Fig. 3.10).
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Figure 3.9: Gradient with the steps 5.2 - 11.5 - 25.7 - 31 - 35 - 39 - 45% on a 10ml
HP Q column
Figure 3.10: Two HP Q runs: left: 0-35-36-44%, right: 0-31-36-44%
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The samples were then purified with gel filtration. Based on the assumption that
Ferredoxin is a small protein, it was expected to be eluted from the column rather towards
the end. Thus, the second and the third peak were tested, and the first peak ignored. When
tested on SDS-PAGE, both peaks had a trace of the target protein (reapplied colour as
the original bands have faded) and the highest peak presented with a strong band in the
110-160 kDa region (Fig. 3.11). Neither, however could present the overexpressed band,
which implies that the protein might have been in the first peak.
Figure 3.11: Gel filtration to Fig. 3.10 of the 0-31-36-44% step gradient
With an eluding window of 30-36%, samples 3 and 8 were collected and further
purified by gel filtration, where sample 3 was split into samples A & B plus sample 8 (Fig.
3.12). Here the target protein was released in all three cases in the first peak, which was
continuous across all gel filtrations, as shown in another sample that was used for the second
crystallization attempt (fig. 3.13). Therefore, the protein is despite its small size contrary to
belief eluted early in the gel filtration. One possibility would be that the apoprotein forms
dimers or bigger complexes, which cause the early release.
Besides the missing amino acids, the poor peaks might indicate the possibility
of protein loss during the purification and filtering procedures. Therefore samples were
collected throughout the previous steps up to IEX. As can be seen in Fig. 3.14), a clear
band for 11 kDa can be observed across all samples except for sample 4, which presents the
non-precipitated proteins in the ammonium sulfate precipitation step. Thus, the protein
concentration would not dwindle drastically during the purification procedures.
Due to the purification issues, the idea arose that perhaps changing the IEX col-
umn. HP Q is a standard in the group but the literature on ferredoxin states consistently
DEAE-cellulose as raisin of choice (Bruschi and Guerlesquin, 1988; Green et al., 2003). Al-
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Figure 3.12: Gel filtration with possible overload
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Figure 3.13: Gel filtration with samples before third crystallization attempt
Figure 3.14: SDS-PAGE checking for protein loss
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though DEAE is a weaker binding column than HP Q, the benefit of doubt based on the
literary evidence was applied. Although the ferredoxin was not eluted at a particularly high
salt concentration, rather in the region 30 - 36%, the hope was that the DEAE column might
separate the target protein and the E. coli proteins more adequately. Therefore samples were
split into two parts after the desalting process. One half was applied to the DEAE column,
and the second half to the HP Q column. Examples for the results can be seen in Fig. 3.15
and Fig. 3.16 . The yellow marked samples in Fig. 3.15 went on to gel filtration (Fig. 3.17)
Based on the findings from the previous gel filtration, this time the first peaks (blue arrow)
were chosen, resulting in the expected bands on the SDS-PAGE. In terms of improved sep-
aration the DEAE did not fulfill the expectation. Thus, contrary to the literature, HP Q
columns under consideration of the right pH have proven to be the most suitable choice.
Another factor playing a role in the detection of holo-ferredoxin is the chromophore
cluster. The detection was aggravated from the beginning due to the lack of colour. The
slightly tinted sample after the desalting step turned into a clear solution during the IEX
chromatography. Hence, an identification by the wavelength of the chromophore was not
possible. For the first half of the experiments, DTT was added as reducing agent throughout
the whole purification process, as this is a standard agent. DTT was then replaced by BME,
which has been frequently used in ferredoxin purification in the literature. The result of
changing the reducing agent caused a more stable yellow colouring of the sample throughout
the purification process, where even at the end the sample would provide a yellow hue (Fig.
3.18).
Following the development in colour or lack thereof, the wavelenghts were changed
occasionally to find out if a better detection could be achieved. They are presented in
chronological order in Tbl. 3.1 with the final suggestion of 280 nm, 305 nm, and 330 nm.
The second last reading was 280 nm, 305 nm and 390 nm. However, the display of 390 nm
was not particularly telling, 305 nm was acceptable. Hence, 390 nm was changed into 330
nm, which provided a reasonable satisfactory result. In account has to be taken that even
in the case of colour it was not given that the sample stayed coloured till the end of the
purification process or that the colour was indeed provided by BC2795 and not by a protein
of E. coli. What the previous runs showed that the settings 320 nm, 390 nm, 400 nm, and
414 nm were not sufficient enough for a reading. When 414 nm were tested, no reading was
found due to the lack of the cluster and therefore this wavelength had been discarded. The
curves for 260 nm matched the curves 280 nm and were therefore changed into a different
wavelength that might provide some not yet given information. The ÄKTApurifier does
not record across a wider span of wavelength like an UV-vis spectrophotometer but allows
only the setting of three specific wavelengths. Hence, changing one wavelength setting
automatically leads to the loss of the previous setting. Due to the persistent presence of
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Figure 3.15: Comparison HP Q and DEAE columns I
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Figure 3.16: Comparison HP Q and DEAE columns II
Figure 3.17: Gel filtration of the HP Q and DEAE comparison
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Figure 3.18: Colour hue change from DTT to BME
colour in the sample in the second half of the project, a new attempt was made in changing
a wavelength towards the end. Based on a study by Dailey et al. on human ferrochelatase,
this iron-sulfur protein with a [2Fe-2S]cluster presents with a peak at 415 nm, which stems
from trace amounts of high spin Fe (III). It also has peaks at 330, 460, and 550 nm (Dailey
et al., 1994). As towards the end of the project only one wavelength could be changed, 330
nm was chosen.
As the sample now presented itself with colour, the hope rose to see also the in
the literature stated “coffee coloured band” on the column, allowing to follow the eluting
process (Fig. 3.19) (Valentine, 1964). However, it turned out that the band disappeared
already before the target protein was eluted, which implies that in collected cells from the
overexpression the red colour is likely to be provided by E. coli.
Figure 3.19: Coffee brown band on HP Q column
Despite following the standard protocol for protein purification, the SDS-PAGE
would after the Gel filtration still show more bands then only the expected 11 kDa band
for BC2795 (fig. 3.20). Two attempts were made: the first suggestion was to start after the
desalting with the gel filtration, which should then be followed by an IEX chromatography.
The second suggestion was to introduce an additional IEX purification at the end: IEX -
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Settings
1st 2nd 3rd comments
(nm) (nm) (nm)
280 390• 400* *Nakamura et al. (1999), •Hong and Rabinowitz (1970)
280 390• 414◦ ◦Chen et al. (2011); Gilevich et al. (1985)
Meyer et al. (1984)
280 390• 400*
260 280 390•
280 305 390• Bruschi and Guerlesquin (1988)
280 320∝ 390• ∝Meyer et al. (1984); Gilevich et al. (1985)
280 305 330/ /Blazyk and Lippard (2002); Dailey et al. (1994)
280 nm was used throughout as standard due to its relevance
to protein detection in general. For the detection of Phenylalanine,
260 nm were used in half of the experiments. The wavelengths
390 nm, 400 nm, and 414 nm showed not sufficient response to
the samples.
BC2795
nm code amount amino acid
280 W 0 Tryptophan - most absorbent
274 Y 0 Tyrosine
257 F 2 Phenylalanine - absorbs less than W & Y
Table 3.1: Applied UV-vis wavelengths with ÄKTApurifer
gel filtration - IEX. The first suggestion with the gel filtration at the start turned out to be
implausible due to the high liquid volume and also high protein concentration, which would
require ca. 10 - 20 gel filtrations steps to purify a 10 - 20 ml sample. The second suggestions
is a standard method, which however came to an abrupt hold due to the loss of the protein.
As this experiment was run at the end of the project, there was no time to rerun it.
One suggestion was that the overexpressed proteins might already shortly after
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Figure 3.20: Purity Problem
the overexpression begin to lose their cluster. Another explanation that reduced ferredoxin
presents itself colourless, whereas oxidized ferredoxin has been found to be green or brown,
depending on the species (Green et al., 2003; Valentine, 1964). Therefore, two further
approaches were considered: reconsitution of the Fe-S cluster and a small redox experiment.
3.1.4 Protein concentration & Cluster reconstitution
To identify the protein concentration, the lack of Tyrosine and Tryptophan in the sample
did not allow the standard determination with UV-vis with Beer-Lambert law. Instead,
the Bradford assay was applied. The concentrated samples from the gel filtration were in
general only of small amount (max. 1.5 ml). Thus, each sample could not only not be further
concentrated but was also limited in terms of reproduction of crystallization conditions. The
first standard curve was created with myoglobin (Sigma Aldrich). Following the resulting
curve, there was some doubt about the validity. To make sure that this was a reliable
standard, a “professional” kit with Bovine Serum Albumin (BSA) was bought and set as the
new standard [0.1, 0.2, 0.3, 0.5, 0.8, and 1 mg/ml] (Fig. 3.21). Independent of the standard,
there is a fluctuation possible up to a factor of 2. Additionally is the results also dependent
on how much the given compound absorbs of the Bradford solution. Therefore, the standard
curve, independent of the source, can only be seen as a guide. The Bradford assay was run
on all samples that were considered for crystallization. The assay was also applied in the
reconstitution attempts as described further down.
The colour change from purple to blue indicates the protein concentration of the
sample (Fig. 3.22). The samples in this assay series were tested for their protein content for
three different reasons. The samples I, II, and III were old samples from the beginning of
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Figure 3.21: BSA standard curve
the project. Sample III was applied to reconstitution. The samples IV, V, and VI tested for
the possible loss of protein during the washing procedure after the reconstitution. Sample
VII shows the reconstituted sample III that presents now without protein. Number VIII
had been used for the first crystallization with the crystals presented in the next section.
And the IX was the check on the last gel filtration sample to identify it as possible candidate
for the next crystallization round.
Figure 3.22: Samples I-IX from Bradford test
The same was done with other samples like in Table 3.3, which all three were
applied to the third crystallization round. None produced crystalls. The flaw in the approach
till then was that none of the blue coloured samples had been tested on a dilution series. As
the standard curves shows ceiling effect after 2 mg/ml due to oversaturation, the required
concentrations for crystallization cannot be measured without diluting the samples in several
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steps. The change in protein concentration becomes apparent with 3.4, where the original
sample undergoes three diluting steps up to one tenth. Thus, instead of being a guessed 2-3
mg/ml, the dilution showed a concentration of assumed 8 mg/ml.
3.1.5 Protein Crystallography
3.1.5.1 Protein crystallization
Four crystallization attempts were made. The first set was performed on the Oryx6 Robot
(Douglas Instruments Ltd), and the JCSG+ suite (Qiagen). Four crystallization conditions
gave similar pyramidal shaped crystals as shown in Fig. 3.23 for conditions E4, F7, F11,
and G12 (Table 3.6).
Crystals from four different conditions were transferred to the corresponding cryo-
solution and flash-frozen in liquid nitrogen after 10-30 seconds. An overview of the frozen
crystals prepared for X-ray diffraction analysis at the synchrotron is shown in table 3.6.
In the three later attempts, the crystallization was not successful.
measured adjusted
sample absorption absorption
SMPLI 1.081 1.202
SMPLII 1.117 1.239
SMPLIII 1.230 1.352
SMPLIV -0.121 0.000
SMPLV -0.015 0.106
SMPLVI 0.185 0.307
SMPLVII 0.068 0.189
SMPLVIII 0.473 0.595
SMPLIX 0.852 0.974
Table 3.2: Data for Fig. 3.22. For the fourth crystallization, sample III (SmplIII)
was used.
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Figure 3.23: Crystals
3.1.5.2 X-ray data collection
The crystals diffracted to different resolution, and data were collected for four of the crystals.
The four data sets were auto processed by the beamline software, and all indicated the cubic
space group F432 with cell axes of 220 Å. In Figures 3.24 & 3.25 the 110 x 110 x 110 µm3
crystal from condition F11 is shown together with one of the diffraction images.
The data set showing the highest resolution was selected for further processing.
The diffraction images were index and integrated with XDS, the space group confirmed to
be F432 by POINTLESS within the AIMLESS program which also scales the data (Kabsch,
2010; Evans, 2011). Diffraction data was collected to 2.0 Å resolution and for 360◦. Due to
the high symmetry, only 60◦ of data was needed to obtain a complete data set. This also
limited the radiation damage of the crystal., and to obtain satisfactory scaling statistics,
the resolution was cut to 2.3 Å. Matthews coefficient analysis indicated that there were four
molecules in the asymmetric unit giving a Matthews coefficient of 2.4 Å3 Da−1 and a water
content of 49% (Matthews, 1968). The crystal statistics are shown in Table 3.6.
sample absorption
C 1.178
D 1.206
E 1.248
Table 3.3: Three gel filtration samples for crystallization
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Figure 3.24: Diffraction I of crystal from condition F11
3.1.5.3 Structure determination
To solve the structure with molecular replacement a starting model structure, which is
structurally homologous has to be used. A BLAST search (Altschul et al., 1990) against the
Protein Data Bank (PDB) resulted in the most sequence similiar structure being a 2Fe2S
ferredoxin trimer from E. Coli with PDB-code 1I7H. This ferredoxin had a sequence coverage
of 90% with an identity of 31% (Kakuta et al., 2001).
Molecular replacement was performed with PHASER using 1I7H in three different
assumed
sample absorption concentration dilution
1/10A 0.413 0.8 1/10
1/5A 0.634 1.6 1/5
1/2A 0.776 4 1/2
141016CRYS-A 0.829 8 1
Table 3.4: Dilution series
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Figure 3.25: Crystal from condition F11
ways: I. using a poly-Ala model of 1I7H, II. using a homolog model generated by Swiss-
model (Schwede et al., 2003), III. using the 1I7H poly-Ala trimer. Additionally, similar
models using three other types of ferredoxins among the ones with highest sequence similarity
(PDB-codes 1E9M, 3LXF, 4ITK) was tried. None gave a result with a translational-scoring
value (TFZ) above 8, which would have indicated that the structure was solved. Here the
values were in the range 4-5, which shows that the structure has not been solved.
The data was also submitted to the MrBUMP program (Keegan and Winn, 2007)
at the CCP4 online server (http://www.ccp4.ac.uk/ccp4online). This is an automatic pipeline
using the molecular replacement programs PHASER and MOLREP (McCoy et al., 2007;
Vagin and Teplyakov, 1997), as well as testing out models generated from several homolo-
gous PDB-structures. This server generated models from 10 PDB files (1I7H, 3AH7, 3ZYY,
1KRH, 3N9Z, 2MJ3, 3HUI, 2Y5C, 1JQ4, 2WLB15) and generated two models from each
by using two different programs SCULPTURE and MOLREP. Additionally, an ensemble
Location Crystallization condition
E4 0.2 M Lithium sulfate, 0.1 M Tris pH 8.5, 1.26 M Ammonium sulfate
F7 0.8 M Succinic acid pH 7.0
F11 1 M Succinic acid pH 7.0, 0.1 M HEPES pH 7, 1% PEG MME 2000
G12 3 M Na chloride, 0.1 M bis-Tris pH 5.5
Table 3.5: Crystallization conditions
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model was made, which is the mean of the PDB-files used. These 21 models, was then run
with both PHASER and MOLREP, however, no solutions were found.
This shows that it is very difficult to be able to solve the structure with molecular
replacement from these crystals. The reason for the molecular replacement to fail can be
due to several reasons. One possibility is that the structure of BC2795 is not structurally
homologous enough with respect to the model. Another possibility is that the apo structure
without FeS-cluster have some conformational differences with respect to the holoprotein,
therefore making molecular replacement difficult. A third possibility is because of the very
large unit cells (220 Å) and the number of protein molecules in the asymmetric unit (four),
which results in the signal needed for placing the first molecule correctly is low an therefore
a difficult task.
To be able to solve the structure an option is to try to obtain another crystals
form with different packing. Secondly, to try to solve the structure with other methods not
depending on a staring model, however this would involve expression of the selenomethionine
variant of the protein or soaking the crystals with different heavy atoms. Since the main
goal of the project is to obtain the holoprotein structure, these attempts on the apoprotein
was not further pursued.
Screen Antifreeze Crystal size Diffracted Collected
condition µm3 to data set
E4 Glucose 100 x 100 x 100 ≈ 3 Å Yes
E4 Glucose 80 x 80 x 80 5-6 Å No
E4 Glucose 50 x 50 x 50 5-6 Å No
F7 Glycerol 100 x 100 x 100 ≈ 3 Å Yes
F11 Glycerol 110 x 110 x 110 ≈ 2 Å Yes
F11 Glycerol 30 x 30 x 30 ≈ 4 Å No
G12 Glucose 60 x 60 x 60 3-4 Å No
G12 Glucose 50 x 50 x 50 3-4 Å No
Table 3.6: Crystallization statistics
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Crystal data
G12 No
Space group F432
a , b, c (Å) 219.8 / 219.8 / 219.8
( ) 90 / 90 / 90
Crystal size (ţm3) 110 110 110
Data collection
X-ray source ESRF ID23-1
Wavelength (Å) 0.979
Detector Pilatus 6M
Temperature (K) 100
Beam size (ţm2) 45 30
Flux (photons/sec) 8 1011
Resolution range (Å) 44.9-2.30 / 2.38-2.30
Completeness (%)* 99.9 / 100.0
Redundancy (%)* 6.5 / 6.8
I/sd(I)* 16.8 / 2.5
Rsym* 8.7 / 78.9
Total observations 134285
Unique reflections 20724
Mosaicity 0.07
*The value before the backslash is for all
data, and the value after the backslash
is for the data in the highest resolution shell
Table 3.7: Crystal data and data collection statistics
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Figure 3.26: Diffraction II of crystal from condition F11
Figure 3.27: Crystal from condition F11 from different angle
50
3.2. FERREDOXIN WITH [4FE-4S] CLUSTER - BC1483
Figure 3.28: BC1483 cultures with 10 µl cells and 1, 2 or 3 µl plasmid
3.2 Ferredoxin with [4Fe-4S] cluster - BC1483
3.2.1 Molecular Cloning and overexpression of BC1483 Ferredoxin
The cloning attempts with BL21 cells and BC1483 were successful but the protein was
not overexpressed in the test run. Although positive transform colonies grew on the agar
plates (Fig. 3.28), the cell lysis step of the overexpression did not produce any bands. The
experiment was repeated two times with different colonies, each with the same outcome
(Fig. 3.29 & 3.30).
Figure 3.29: BC1483 cell transformation results
Based on the assumption that some proteins can be either toxic to the host cell
or otherwise damaging to the overexpression process, a different cell line was tested: C41
that has successfully been used for expression of other ferredoxins (Kakuta et al., 2001).
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The lysed cells of the overexpression would show one band for colony 2A but also show a
band for the sample from before the induction (Fig. 3.31). A standard overexpression was
set up for the 2A sample but without any outcome. A second repeat came to the same
result (Fig. 3.32). The overexpression attempts for the ferredoxin BC1483 was unsuccessful,
both for the standard BL21 cells and the more tolerant C41 cells. The reason for the failed
overexpression was not clear, and therefor at this stage no further attempts were made for
overexpression of the BC1483.
Figure 3.30: Second attempt to transform and overexpress BC1483
Figure 3.31: Transformation and overexpression with C41
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3.2. FERREDOXIN WITH [4FE-4S] CLUSTER - BC1483
Figure 3.32: Second attempt of BC1483 overexpression with C41 cells
3.2.2 BC1483 - Sequence confirmation
Figure 3.33: Sequence comparison of BC1483
The sequence of BC1483 is as by BC2795 identical to sequences found in other
members of the B. cereus family (Fig. 3.33). Due to issues with the overexpression of
BC1483, the question arose if the bought plasmid might carry a fault. Therefore the plasmid
was sent to GATC Biotech for analysis, who provided the information as seen in Fig. 3.34.
The supplied sequence file (Fig. 3.34) was then aligned with BLAST against the
sequence of the ordered BC1483 in B. cereus (Fig. 3.36 & 3.35). The outcome showed a
mismatch, however, a manual inspection of the chromatogram (Fig. 3.37) showed a clear
misinterpretation showing that the NCNN clearly was a GTT. The sequencing therefor
confirmed that the sequence of the ordered plasmid was correct, and the unsuccessful over-
expression of BC1483 could not be due to errors in the cloned plasmid.
53
3.2. FERREDOXIN WITH [4FE-4S] CLUSTER - BC1483
Figure 3.34: Plasmid sequence
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3.2. FERREDOXIN WITH [4FE-4S] CLUSTER - BC1483
Figure 3.35: Sequence alignment plasmid and Bacillus cereus genome
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3.2. FERREDOXIN WITH [4FE-4S] CLUSTER - BC1483
Figure 3.36: Blast graphic sequence aligment
Figure 3.37: sequence hickup
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4
Conclusions - Implications & Future Research
Looking back, this project could have been more fruitful.
The BC2795 ferredoxin is easy to overexpress and allows a simple one step ammo-
nium sulfate precipitation. If it is applied to HPQ columns with a pH 8.2, sufficient bonding
to the raisin will given, and thus providing a good basis for separation by IEX. Slight fluc-
tuations in the eluding window during IEX with HP Q can be due to pH imbalances in the
running buffers. The window setting of 30 -36% however should allow a safe frame. However,
even here, the samples might need to be controlled with SDS page as the overexpression
cannot be shown as pronounce on the chromatogram as with other proteins that contain
tryptophane and tyrosine. If buffer A contains 100mM of KCl, which is suggested for the
stabilization of the cluster, the eluting window moves accordingly downt to ca. 20-26%. The
question, why BC2795 is eluted so early in the gel filtration might be an interesting coin-
cidence because the question indicates the presence of apoprotein complexes. Throughout
the project, the iron content was never estimated. Something that should be done in case
of a follow up. Thus, if cluster reconstruction were successful, would the sample accordingly
elute at a later step? The reconstitution attempts were not successful and also led to the
drastic loss of the protein during the cleaning process. Hence, this process requires more
refinement. Although the change in reducing agent from DTT to BME caused an improve-
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ment in colour, this might be primarily caused by E. coli proteins. Hence, testing a variety
of reducing agents might give more insight into the question of the cluster behaviour in this
ferredoxin. Of the crystallization suites applied, the only successful one was the JCSG+
suite, something that could be further advanced with more purified samples. The search
for the “ideal purification” process led parts of this project astray and stranded. If picked
up at this spot, more effort would need to be put into the reconstitution of the cluster and
additional applications of related methods including EPR, in case of crystals also Raman
spectroscopy.
For the BC1483 ferredoxin, the main hurdle till now is the not achieved overex-
pression. As some ferredoxins are stated to be oxygen sensitive, this might need to tested,
if possible also with BC2795.
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Abbrevation Name
A absorption
aa amino acid
Å Ångström
B. anthracis Bacillus anthracis
B. cereus Bacillus cereus
B. subtilis Bacillus subtilis
B. thuringiensis Bacillus thuringiensis
B. weihenstephanensis Bacillus weihenstephanensis
BME β-mercaptoethanol
bp base pairs
BSA Bovine serum albumin
C-terminal carboxyl-terminal
Da Dalton - atomic mass unit
DNA deoxyribonucleic acid
DTT Dithiothreitol
E. coli Escherichia coli
et al. et alii (latin) - and others
EtOH Ethanol
FAD flavin adenine dinucleotide, oxidized
FADH2 flavin adenine dinucleotide, reduced
FMN Flavin mononucleotide
g G force (gravitational acceleration)
IPTG Isopropyl β-D-1-thiogalactopyranoside
LB Lysogeny broth
mqH2O Milli-Q filtered and ion-exchanged water
N-terminal amino-terminal
NADP+ Nicotinamide adenine dinucleotide phosphate, oxidized
NADPH Nicotinamide adenine dinucleotide phosphate, reduced
OD optical density
PAGE polyacrylamide gel electrophoresis
PDB Protein Data Bank
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Abbrevation Name
rpm revolutions per minute
SDS sodium dodecyl sulfate
SDS-PAGE SDS polyacrylamide gel electrophoresis
TB terrific broth
Tris Tris(hydroxymethyl)aminomethane
UV light Ultraviolet light
UV vis spectroscopy Ultraviolet visible spectroscopy
 molar extinction coefficient
λ wavelength of electromagnetic radiation
Units of measurements
◦C Degrees Celsius Da Dalton
g G force kDa kilo Dalton (103 Da)
l litre g gram
ml millilitre (10−3 l) mg milligram (10−3 g)
µl microlitre (10−6 l) µg microgram (10−9 m)
nl nanolitre (10−9 l) ng nanogram (10−9 m)
mol mole Å Ångström (10−10 m)
M molar (1 mol/L)
mM millimolar (10−3 M) V Volt
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Amino acids
Amino acids Three letter code One letter code
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic acid Asp D
Cysteine Cys C
Glutamic acid Glu E
Glutamine Gln Q
Glycine Gly G
Histidine His H
Isoleucine Ile I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
Table 5.1: Amino acids
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Chemicals
Chemical Manufacturer
Acetic acid Merck KGaA
Ammonium sulfate Merck KGaA
Ampicillin sodium salt Sigma Aldrich
BactoTM agar Becton, Dickinson & Co.
β-mercaptoethanol Sigma Aldrich
Bovine Serum Albumin standard, prediluted GBiosciences
Bradford Assay Dye Reagent Bio-Rad laboratories
Brilliant Blue R250 Sigma Aldrich
Carbenicillin disodium salt Sigma Aldrich
Ex-Cell Antifoam Sigma Aldrich
Dithiothreitol (DTT) Sigma Aldrich
Ethanol Arcus Produkter AS
Ferric Ammonium Citrate (Fe content 16.5-18.5%) Sigma Aldrich
Glycerol bidistilled 99.5% VWR chemicals
Hydrochloric acid ≥ 37% Sigma Aldrich
Hepes Sigma Aldrich
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Thermo Scientific
Potassium Chloride Merck KGaA
Lysozyme Chloride, Grade VII Chicken Egg White Sigma Aldrich
Myoglobin Sigma Aldrich
NucleoSpin Plasmid - Plasmid DNA isolation Miniprep kit Macherey-Nagel
NuPAGE (R) Bis-Tris Mini Gels (10 & 15 wells) Novexr
Sharp Pre-stained Protein Standard Ladder Novexr
Sodium Cloride Merck KGaA
Spectra multicolor Low Range Protein Ladder Thermo Scientific
Dipotassium hydrogen phosphate (K2HPO4) Merck KGaA
Potassium dihydrogenphosphate (H2KPO4) Merck KGaA
Streptomycin sulfate salt Sigma Aldrich
Tris(hydroxymethyl)aminomethane (Tris) VWR Chemicals
Trypton Sigma Aldrich
Yeast Extract Merck KGaA
Table 6.1: Chemicals
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Chromatographic column materials
Column Manufacturer
HiTrapTM Desalting GE Healthcare
HiTrapTM Q HP 5ml GE Healthcare
HiTrapTM DEAE FF 5ml GE Healthcare
HiLoad 26/10 Q Sepharose HP GE Healthcare
HiLoad 16/60 Superdex 200 GE Healthcare
Table 6.2: Chromatographic column materials
Crystallization kits
Crystallization kit Manufacturer
Index Hampton Research
JCSG+ Qiagen
Morpheus I & II Molecular Dimensions Ltd
NatrixTM Hampton Research
NatrixTM 2 Hampton Research
Wizard Classic 1 & 2 Rigaku Reagents, Inc.
Table 6.3: Crystallization kits
Cells & Plasmids
Cells Source
One Shot (R) BL21 (DE3) InvitrogenTM
One Shot (R) BL21 (DE3) pLysE InvitrogenTM
C41 (DE3) Lucigenr
Plasmids pET-22b(+) GenScript
BC1483 GenScript
BC2795 GenScript
Table 6.4: Cells & Plasmids
65
Instruments
Instrument Function Manufacturer
Milli-Q plus mqH2O Pump filter Millipore
Tomy SS-325 small autoclave Tomy
Emmer autoklav large autoclave Emmer
BioCen20 table centrifuge Orto Alresa
Avanti J-25 Centrifuge large centrifuge Beckman
Avanti J-20XP Centrifuge large centrifuge Beckman Coulter
Electrophoresis EPS-600 SDS PAGE power supply Pharmacia Biotech
Dri-Block DB-2D heat block Techne
G-25 big shaker New Brunswick Sc.
Series 25 incubator shaker small shaker New Brunswick Sc.
Agilent 8453 spectrophotometer UV vis spectroscopy Agilent Technologies
REAX 2000 Vortex Heidolph
ÄKTApurifer purifier system Amersham pharmacia
HP 8452A Spectrophotometer spectrophotometer GE Healthcare
JA-10 rotor centrifugation Beckman Coulter
JA-25.50 rotor centrifugation Beckman Coulter
NanoDrop (ND-1000) spectrophotometer Thermo Scientific
pH meter (PHM 240) pH meter Radiometer Analytical
Oryx6 Robot crystallization Douglas Inst. Ltd
Mosquito LCP crystallization TTP Labtech
Table 6.5: Instruments
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Equipment
Equipment Manufacturer
Amicon Ultra (10K) Millipore
Amicon Ultra 4 Centrifugal Filter Millipore
Centricon Plus-70 Centrifugal Filter (10K) Millipore
Cryo loops Hampton Research
Crystallization plates Qiagen
Gastight syringes Hamilton
PCR-tubes Axygen
Petri dishes Satrstedt
Parafilm Parafilm
Pipette tips VWR
Cuvettes Brand
Microfilters Sarstedt
Rubber O-rings for X-press (44.12 x 2.62 mm) Vestpak AS
Table 6.6: Equipment
Software
Software Source
845 x UV visible Chem Station Agilent Technologies
Unicorn 5.31 (Build 743) 2011 (Äkta) Unicorn Control Software (GE Health Care)
Unicorn 5.11 (Build 407) 2006 (Äkta) Unicorn Control Software (GE Health Care)
Table 6.7: Software
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Buffers
Phosphate buffer - pH 7.5 Concentration Molecular weight
KH2 0.17 M 136.09 g
K2H 0.72 M 174.18 g
mqH2O
Buffer A - pH 8.2 - 2l (degassed) Concentration Volume
Tris HCl stock [1M] 50 mM 100 ml
KCl [3M] (in the 1st set not added) 100 mM 67 ml
mqH2O
BME [1M] 1 mM 2 ml
or
DTT 2 mM 617 mg
Buffer B - pH 8.2 - 1l (degassed) Concentration Volume
Tris HCl stock [1M] 50 mM 50 ml
KCl [3M] 1 M 333 ml
mqH2O
BME [1M] 1 mM 1 ml
or
DTT 2 mM 308.5 mg
Gel filtration Buffer - pH 8.2 - 1l (degassed) Concentration Volume
Hepes stock [1M] 50 mM 50 ml
KCl [3M] 100 mM 33 ml
mqH2O
BME [1M] 1 mM 1 ml
or
DTT 2 mM 308.5 mg
Table 6.8: Buffers
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Stocks & Media
LB-medium - 0.5 l Weight
NaCl 5 g
Tryptone 5 g
Yeast extract 2.5 g
mqH2O
LB-medium for plates - 0.5 l Weight
NaCl 5 g
Tryptone 5 g
Yeast extract 2.5 g
Agar agar 10 g
mqH2O
TB-medium - 1 l Weight
Tryptone 12 g
Yeast extract 25 g
Glycerol 4 ml
mqH2O 0.9 l
Glycerol solution 60%
Glycerol 50 ml
mqH2O 30 ml
Ampicillin Stock 1:0.001
For 500 ml [100 µg/ml] 500 µl [100mg/ml]
For 1l need 1 ml
Bacterial Stock
Bacteria 800 µl
Glycerol 60% 200 µl
Table 6.9: Stocks
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Stocks & Media
Novex staining solution
Brilliant Blue R250 0.1 %
Ethanol 40 %
Acetic acid 10 %
mqH2O
Novex destaining solution concentration
Ethanol 10 %
Acetic acid 7.5 %
mqH2O
Tris buffer
Tris 100 mM
DDT 2 mM
10% Stryptomyecin Sulfate Solution pH7.5
Stryptomyecin 10%
mqH2O 1/4 volume of supernatant
IPTG
0.5M in 1ml 0.5mM in 1l
1M in 1ml 1mM in 1l
Make [0.5M]: 50 ml with 5.958 g IPTG, 41.96 ml with 5 g
β-mercaptoethanol (BME)
349.65 µl BME [14.3 M] for 5 ml BME [1 M]
Table 6.10: Stocks
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Gene name: BC1483 - Length: 258 bp
Additional 5’ sequence: CAT
Additional 3’ sequence: GGATCC
Vector name: pUC57 - Plasmid preparation: 4 ug
Sequence:
CATATG GCAAAATATACAATCGTTGATAAAGATACTTGTATTGCATGTGGTGCTT
GTGGCGCTGCTGCACCAGACATTTATGACTATGATGATGAAGGTATTGCATTTGT
AACATTAGATGATAACCAAGGTATCGTTGAAATTCCAGATGTATTAATTGAAGAT
ATGATGGATGCATTCGAAGGCTGTCCAACTGACTCAATTAAAGTTGCTGACGAA
TCATTCGACGGAGACGCTTTAAAATTCGAA TAA GGATCC
Custom Cloning: BC1483 pET-22b(+):
Vector name: pET-22b(+) - Plasmid preparation: 4 µg
Cloning site: NdeI/BamHI
Gene name: BC2795 - Length: 330 bp
Additional 5’ sequence: CAT
Additional 3’ sequence: GGATCC
Vector name: pUC57 - Plasmid preparation: 4 µg
Sequence:
CATATG CCAAAATTAACAATTGAAGGTGCGGGAACTTTTGATGTGAAAGAAGGAA
CAAAGTTAGTATTAGCAATTGAAGATAGCGGTGTCAACATTCTTCATCGTTGCGGC
GGGAATGCACGTTGCACAACTTGTAGAGTAGAAATACTAGCAGGTGATTTCTGTG
AAGCGAGTGCGAATGAGAAACATGCAATGACGGAAAAAGGAATTGAAGATCACT
TTACGATTATCTTGTCAAATGCGTGTACATAAAGATATAGTCGTTCGTCCGGTATT
ACAGTTGAAAATTCAGGTCTTGATGCTGGGCCACGTCCGGCGGAG TAA GGATCC
Custom Cloning: BC2795 pET-22b(+):
Vector name: pET-22b(+) - Plasmid preparation: 4 µg
Cloning site: NdeI/BamHI
Table 6.11: Ordered Sequences
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Appendix - Protocols
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Figure 7.1: P1 Plasmid
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Figure 7.2: P2a Overexpression Test Run & Autoclave
74
Figure 7.3: P2b Overexpression Test Run Lysis & SDS-PAGE
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Figure 7.4: P3a Overexpression
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Figure 7.5: P3b Overexpression & Lysis
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Figure 7.6: Purification
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Figure 7.7: P5 Desalting with Äkta
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Figure 7.8: P6 IEX column (HP Q)
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Figure 7.9: P7 Gelfiltration
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